TrialFrontiers in immunology2021

Sequential Transplantation of Haploidentical Stem Cell and Unrelated Cord Blood With Using ATG/PTCY Increases Survival of Relapsed/Refractory Hematologic Malignancies.

Hua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.